Arkolith/Insider Trading/RGNX/Form 4

Simpson Curran

Chief Executive Officer, DirectorREGENXBIO Inc. (RGNX) · full profile →Form 4 · filed Sep 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$77K
Net Open-Market Flow
-$77K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 10, 2025Sell(S)8K$10.02$77K245K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-006194) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML